Related Experiment Videos
[Mono Mac 50D treatment results in patients with chronic coronary heart disease]
Insights
Mono Poppy 50mg effectively treated angina pectoris in patients post-bypass surgery, post-heart attack, and with stable angina. The medication improved physical tolerance and reduced nitroglycerin use with minimal side effects.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Angina pectoris significantly impacts patient quality of life and treatment outcomes.
- Current therapeutic strategies for angina pectoris require optimization for efficacy and safety.
Purpose of the Study:
- To evaluate the therapeutic efficiency and safety of Mono Poppy 50mg in patients with various forms of angina pectoris.
- To assess the impact of Mono Poppy 50mg on physical tolerance and nitroglycerin dependency.
Main Methods:
- A 3-month observational study involving 22 patients with angina pectoris.
- Patients were categorized into three groups: post-coronary artery bypass grafting, post-myocardial infarction, and stable angina pectoris.
- Dosage ranged from 25-50 mg/day, with regular monitoring of symptoms and medication use.
Main Results:
- Mono Poppy 50mg demonstrated significant stabilization of condition in the majority of patients.
- Patients experienced increased physical load tolerance and a marked reduction in nitroglycerin use (from an average of 8 to 2 per week).
- Headache was the only noted side effect in one patient, requiring a dose reduction.
Conclusions:
- Mono Poppy 50mg exhibits favorable efficacy and safety profiles for managing angina pectoris.
- The drug can potentially reduce reliance on other anti-anginal medications, thereby decreasing overall treatment burden and cost.
- Mono Poppy 50mg offers a valuable therapeutic option for diverse angina pectoris patient populations.
Abstract:
In functioning valued efficiency an [symbol: see text] of the form [symbol: see text]-5-[symbol: see text] Mono Poppy 50[symbol: see text] for the treatment within 3 months beside three groups sick: under saving angina pectorises after operations of [symbol: see text] bypassing (6 persons), after the heart attack [symbol: see text] (5 persons) and under stable angina pectorises (11 persons). Beside majorities sick to manage to obtain stabilizations of the condition an [symbol: see text] Mo[symbol: see text]a Poppy 50[symbol: see text] in the dose 25-50 mgs/cym on length 3 months of observations. Herewith noted increasing [symbol: see text] to the physical load, reduction of the frequency of receiving a nitroglycerine at the average with 8 before 2 at a week once. Side effects In the manner of the denominated headache noted beside one patient only that has required a reduction of the dose in two times. As a whole, made output on that that Mono Poppy 50[symbol: see text] possesses a good [symbol: see text] and [symbol: see text] effect, in many events allows to obtain to abandon to using of other [symbol: see text] preparations that not only reduces a total [symbol: see text] load on the organism of the patient, as well as reduces overall value of the treatment.